텔라 바이오 (TELA) 주가

텔라 바이오(TELA)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.64 (-4.97%), 시가총액 $0.04B, 52주 범위 $0.56 ~ $2.14.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in lapar

핵심 지표

• 현재가: $0.64 (-4.97%)
• 시가총액: $0.04B
• 52주 최저~최고: $0.56 ~ $2.14
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

텔라 바이오의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

텔라 바이오 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 7.05
• 순이익률: -0.48%
• 영업이익률: -0.32%

자주 묻는 질문